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The common denominator which binds retinal neovascularization, collaterals, and shunts is the fact that each appears ophthalmoscopically and angiographically as an abnormal vascular channel either within or adjacent to the retina.
RETINAL NEOVASCULARIZATION
The most significant of the three entities clinically, this occurs as a result of some stimulus, the nature of which is not known, provoking pre-existing retinal vessels to proliferate abnormally. The stimulus appears to be related to situations involving poor retinal nutrition resulting in retinal hypoxia and/or the accumulation of metabolic products. Retinal (Wise, Dollery, and Henkind, I971) . In all but the latter, the neovascularization develops from a mature vascular bed that has been compromised by an impediment to flow. In retrolental fibroplasia, the neovascularization develops from an immature retinal vascular bed in which oxygen in high concentration has caused retinal vasoconstriction and vaso-obliteration (Ashton, 1966) ; when the oxygen concentration is reduced to normal, vasoproliferation ensues in response to the previous impedance of retinal vascular flow. In situations in which the circulation is totally compromised, such as retinal artery occlusion, retinal neovascularization does not occur. The reason for this is presumably the fact the retinal cells are dead, and cannot provide the stimulus necessary for neovascularization. The fact that the retinal vascular cells are themselves dead and are thus unable to proliferate, may also be a significant factor.
Retinal neovascularization usually appears most often at the disc and near the larger retinal veins, but may develop from any point in the retinal vascular bed, and grow either superficially towards the vitreous, or downwards beneath the retina. Early neovascularization may appear as tufts of irregular, fine vessels on the retinal surface (Fig. i) . These new vessels may remain localized; they may grow profusely and proliferate into large fronds and complexes, or on rarer occasions they may collapse and become fibrotic and quiescent (Fig. 2 ). Even at their most developed they appear to be of relatively thin calibre. Their mantle of connective tissue, clinically invisible at first, may soon become readily apparent, _ l 1 N | = l l = * | l| m _ W p r e s e n t ( V ) filling patterns, dye leakage, and late staining of the new vessels and their surroundin-g connective tissue (Fig. 3) Venous collaterals (V-V), the most frequent type of collateral seen ophthalmoscopically, develop via the deep capillary bed. This is because the deep capillary bed is more venous in character than the superficial network. They may be observed several weeks after venous obstruction, and are most often seen after branch vein occlusion (Fig. 4) . Venous collaterals develop upon or within the optic disc of patients with central retinal vein occlusion, but in this instance the collaterals develop between the obstructed disc head capillaries (which normally drain into the blocked central retinal vein) and the unobstructed choroidal or pial capillaries draining into patent venous channels. V-V collaterals have been induced in arterial embolization experiments in cats (Henkind, I966). This suggests that reduced retinal arterial perfusion may be equivalent to direct obstruction of retinal veins. Photocoagulation has been used to occlude retinal veins experimentally, with secondary development of V-V collaterals (Kohner, Dollery, Shakib, Henkind, Paterson, de Oliveira, and Bulpitt, 1970) .
Arterial collaterals (A-A) are observed less frequently in human disease than their venous counterparts. They may occur after branch artery occlusion but are rare after central retinal artery occlusion. They may be seen within weeks after an arteriole becomes occluded, but they develop too late to reverse the effects of the occlusion (Fig. 5) . Thus, they serve more as a marker of previous arterial obstructive disease than as a protective mechanism (on the other hand, venous collaterals may help to preserve retinal function in the areas in which they form). (V) and usually have a slow rate of flow (Fig. 6) The macula may also become involved if the angiomatous malformation occurs in the temporal retina, an example of the so-called "exaggerated macular response" (Wise and Wangvivat, f966). Vascular shunts also occur in pulseless disease (Takayasu's disease). Here they probably represent true low pressure shunts, but our experience is too limited to comment further.
Discussion
In the previous section we described three abnormal retinal vascular patterns as distinct entities and, in most instances, the clinician should be able to distinguish between them. There may be occasions, however, when this is difficult. While ophthalmoscopy or slitlamp examination will often suffice, it may be necessary to employ fluorescein angiography to assist in proper diagnosis and management. Also, there are occasions when combinations of the abnormal vascular patterns coexist in a single retinal disease. For example, in diabetic retinopathy, both neovascularization and A-V collaterals may be present in the same fundus. In haemoglobin sickle cell disease, neovascular seafans may occur in areas adjacent to collateral vessels. In branch vein occlusion, both V-V collaterals and neovascular elements may be seen together. Here, however, if neovascularization is prominent, collaterals are usually poorly formed. Conversely, if collaterals are formed early, neovascularization often does not occur.
As in all new classifications, the present system may be incomplete. Further knowledge, especially in the area ofvascular shunts, may require re-evaluation. This classification seems useful in understanding the clinically confusing entities of neovascularization, collaterals, and shunts. Treatment can be rationally planned when the vascular abnormality is properly understood in terms of its aetiology and natural history.
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